DekaBank Deutsche Girozentrale Has $3.78 Million Stock Holdings in National Health Investors, Inc. $NHI

DekaBank Deutsche Girozentrale lessened its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 4.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 53,209 shares of the real estate investment trust’s stock after selling 2,273 shares during the period. DekaBank Deutsche Girozentrale owned 0.11% of National Health Investors worth $3,779,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Allspring Global Investments Holdings LLC grew its stake in shares of National Health Investors by 15.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust’s stock worth $268,000 after acquiring an additional 495 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of National Health Investors by 5.6% in the first quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust’s stock worth $43,494,000 after acquiring an additional 31,451 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of National Health Investors by 11.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust’s stock worth $267,000 after acquiring an additional 357 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of National Health Investors by 3.3% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust’s stock worth $35,372,000 after acquiring an additional 15,497 shares during the last quarter. Finally, New Age Alpha Advisors LLC acquired a new stake in shares of National Health Investors in the first quarter worth $1,868,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on NHI shares. Truist Financial raised their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Cantor Fitzgerald initiated coverage on National Health Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price for the company. National Bankshares set a $90.00 target price on National Health Investors in a research report on Wednesday, October 1st. KeyCorp raised National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research report on Thursday, July 10th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of National Health Investors in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $84.83.

National Health Investors Stock Down 0.2%

Shares of NYSE NHI opened at $75.20 on Friday. The stock has a market cap of $3.57 billion, a PE ratio of 24.03, a PEG ratio of 3.38 and a beta of 0.77. The business has a fifty day moving average of $77.13 and a two-hundred day moving average of $74.27. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $82.32. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.06. The company had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $1.18 earnings per share. As a group, equities research analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 annualized dividend and a yield of 4.9%. This is an increase from National Health Investors’s previous quarterly dividend of $0.90. National Health Investors’s dividend payout ratio (DPR) is presently 117.57%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.